Research Project: Identifying New Ways to Treat Viral Infections in People with Cystic Fibrosis
Grant Awarded:
Emerging Respiratory Pathogen Award
Research Topics:
basic biologic mechanisms
combination therapies experimental therapeutics
modeling
Research Diseases:
COVID-19
cystic fibrosis
Our research focuses on understanding how respiratory viruses impact lungs affected by diseases such as cystic fibrosis. To do this, we use an innovative human airway model developed from induced pluripotent stem cells (iPSCs). These stem cells allow us to create airway tissues that closely mimic real human airways. With this advanced platform, we can study how diseased airways respond to viral infections—including SARS-CoV-2 and other common respiratory viruses. Our goal is to identify new treatment strategies to better protect and heal people living with lung diseases.
The Keith R. Ayres Emerging Respiratory Pathogens Award